{"authors": [["Monge-Ortega", "Olga Patricia", "OP", "Hospital San Juan de Dios, Departamento de Alergia. San Jos\u00e9, Costa Rica. patmo-nor@hotmail.com."], ["Dom\u00ednguez-Ortega", "Javier", "J", null], ["Gonz\u00e1lez-Mu\u00f1oz", "Miguel", "M", null], ["Caba\u00f1as", "Rosario", "R", null], ["Lluch-Bernal", "Magdalena", "M", null], ["Fiandor", "Ana", "A", null], ["Bravo-Gallego", "Luz Yadira", "LY", null], ["Quirce", "Santiago", "S", null]], "text": "Amlodipine is one of the third generation dihydropyridine calcium channel blockers used for hypertension. Mild, moderate and severe reactions have been reported with calcium channel blockers. Cross-reactivity among these drugs has not been established.We have presented the case of a patient who developed a delayed pruritic, and erythematous maculopapular skin exanthema after the intake of amlodipine. A positive lymphocyte transformation test (LTT) confirmed the implication of amlodipine in the reaction and showed positivity to another calcium channel blocker, nifedipine, demonstrating cross reactivity.This is the first reported case of hypersensitivity to amlodipine in which the involvement of the drug is confirmed by a positive TTL. TTL could become a good diagnostic alternative for patients who experience late reactions to amlodipine and possibly cross-reactivity with nifedipine.Antecedentes: el amlodipino es uno de los bloqueadores de los canales de calcio de dihidropiridinas de tercera generaci\u00f3n utilizado para la hipertensi\u00f3n. Se han notificado reacciones leves, moderadas y graves con bloqueadores de los canales de calcio. No se ha establecido la reactividad cruzada entre estos f\u00e1rmacos. Caso cl\u00ednico: se presenta el caso de una paciente con exantema cut\u00e1neo maculopapular, eritematoso y pruriginoso tard\u00edo tras la ingesti\u00f3n de amlodipino. La prueba de transformaci\u00f3n de linfocitos mostr\u00f3 positividad al amlodipino, lo que confirm\u00f3 la implicaci\u00f3n de este f\u00e1rmaco en la reacci\u00f3n; tambi\u00e9n mostr\u00f3 positividad al nifedipino, lo que demostr\u00f3 la presencia de reactividad cruzada. Conclusi\u00f3n: este es el primer caso reportado de hipersensibilidad a amlodipino en el que se confirma la implicaci\u00f3n del f\u00e1rmaco por medio de una prueba positiva de transformaci\u00f3n de linfocitos, la cual podr\u00eda convertirse en una buena opci\u00f3n diagn\u00f3stica en aquellos pacientes que experimentan reacciones tard\u00edas al amlodipino, as\u00ed como posible reactividad cruzada con nifedipino.", "id": "29249113", "date": null, "title": "[Delayed allergic reaction to amlodipine with a positive lymphocyte transformation test].", "doi": "10.29262/ram.v64i4.312", "journal": ["Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)", "Rev Alerg Mex"]}